Ovid Therapeutics's total assets for Q4 2024 were $92.17M, a decrease of -10.22% from the previous quarter. OVID total liabilities were $23.94M for the fiscal quarter, a -9.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.